Search

Jarrod Homer and Stuart Winter: Development of the sixth edition of the UK multidisciplinary head and neck cancer guidelines

Head and neck cancer care is a complex and constantly evolving field. What’s new and how are national guidelines on the subject produced? We spoke to Professors Homer and Winter, the lead authors of the most recent edition of the...

Andreas Wagner: ESPO 2025 keynote speaker

The keynote speaker for ESPO 2025 in Stuttgart is renowned evolutionary biologist and author Professor Andreas Wagner, from Zurich. Prof Wagner will focus on the congress theme of ‘Innovation’, giving us his unique perspective on how evolution drives human creativity....

What can be done to encourage training doctors to pursue a career in paediatric ENT?

Paediatric ENT is often considered the ‘Cinderella’ subspeciality within otolaryngology. There are efforts in the UK and overseas to redress the balance. Paediatric ENT is a specialised field that addresses the unique needs of children with otolaryngological disorders. Despite its...

Wisdom and the cochlear implant clinician

Helen Cullington provides the clinician’s perspective on the challenges faced in building artificial intelligence into cochlear implant clinics. She highlights the importance of including the clinician with their wisdom and experience to help make sense of the patterns of data....

The lessons in setting up a community ENT service in the NHS

Sudeb Mandal, a GP with special interest in ENT, talks about the novel approach taken in the community to deliver ENT services in Kent in the UK. The Kent Community ENT service was born with the vision to bring together...

Listening differences in autistic individuals

In this article Erin Schafer, Lauren Mathews and Andrea Dunn outline the common auditory issues that autistic individuals face in comparison with their neurotypical peers and highlight the need to move beyond the traditional audiologic test battery when working with...

COOL therapy for cisplatin-induced hearing loss

Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...

Rapid genetic testing to avoid hearing loss in neonates

Thousands of newborn babies could avoid a lifetime of hearing loss thanks to a new rapid genetic test. In this article, we learn how. We have demonstrated for the first time that a rapid genetic test from a cheek swab...

Innovations in remote/teleaudiology patient care

Audiometry remains the gold standard in hearing evaluations. Changes in the delivery of audiometry remain a key challenge in providing a telehealth approach to hearing care. The team at Lyon University Hospital validated an innovative approach to solving this challenge,...

Platinum-based chemotherapy, tinnitus and hearing loss

Fortunately, the five-year survival rate of adult cancers is increasing. However, we are seeing for the first time the lasting effects of cancer treatments on people. As more people live with the long-term effects of treatment, such as chemotherapy, it is imperative to understand the impact it has on quality of life.